ArticleTherapeutic advances in medical oncology2024

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.

Yongfeng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.